You are here
Study Chemistry > Current Students > Undergraduate > Senior Freshman
Introduction to Medicinal Chemistry
Prof. Isabel Rozas
Lecture 1 |
History of medicinal chemistry. What is medicinal chemistry? What is a drug? |
Lecture 2 |
Drug safety. The therapeutic index. How a drug exerts its activity? Main phases of drug activity. |
Lecture 3 |
Pharmaceutical Phase. Pharmacokinetic phase: ADME properties (Absorption, Distribution, Metabolism and Elimination) of a drug. Absorption: types of absorption and the role of the pKa and logP of a drug in its absorption. |
Tutorial 1 |
pKa in drug absorption |
Lecture 4 |
Pharmacokinetic phase, continuation. Distribution. Metabolism. Elimination |
Lecture 5 |
Pharmacokinetic parameters: Lipinski rule of 5, clearance, bioavailability, volume of distribution, elimination rate. |
Lecture 6 |
Drug toxicity. Pharmacodynamic phase. Targets: (phospho)lipids, proteins, glyco-lipids/-proteins, nucleic acids. |
Lecture 7 |
Drug-target theories. Drug-Target interactions (covalent bonds, electrostatic, dipole-dipole, charge transfer, van der Waals, hydrogen bonds, hydrophobic). |
Lecture 8 |
How drugs interact with all possible targets considered: phospholipids, protein receptors (agonism/antagonism). |
Lecture 9 |
Protein as targets: enzymes. Different types of inhibition and inhibitors (reversible inhibition, irreversible inhibition, transition state inhibitors). |
Tutorial 2 |
Targeting enzymes: dihydrofolate reductase. |
Lecture 10 |
Nucleic acids as targets. DNA binding (intercalation, alkylation, minor groove binding). Guanine-quadruplexes. |
Lecture 11 |
Drug discovery process: Design and synthesis steps. Identification of a target. Finding a hit/lead compound: serendipity, high-throughput screening (combinatorial chemistry, natural products). |
Tutorial 3 |
Biological evaluation: dose-response curves. |
Lecture 12 |
Optimization process. Structural variations: pharmacophore and bioisosterism. |
Tutorial 4 |
Pharmacophore and bioisosterism examples and salt forms. |
Lecture 13 |
Computer assisted drug design. Molecular modelling: computational methods (ab initio, DFT, molecular dynamics). QSAR: 2D and 3D. “Me-too” drugs. |
Lecture 14 |
Drug development stages: Pre-clinical studies, Clinical phases (1, 2 and 3) and Post-marketing control. |
Back to top